Insmed's freshly approved lung condition drug soared past sales expectations for 2025, netting $144.6 million in its first ...

Study met its primary endpoint demonstrating safety and tolerability of CMTX-101 in people with cystic fibrosisCMTX-101 ...

In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...

Dr. K. K. Pandey  In the Indian subcontinent, individuals of all ages suffer from cough at various stages of life. With the ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $226.22, with a ...

AT JUST 14 years old, Trinity Shores fought flu while in a coma, was hooked up to life support and ‘died’ several times. Chillingly, she could ‘hear and feel everything’ ...

Quantitative CT in AATD linked airway wall thickening and bronchiectasis to lung function, while wall thickness best ...

Insmed outlines 2026 outlook, highlighting BRINSUPRI expansion, ARIKAYCE revenue guidance and multiple late-stage clinical ...

Trinity says half the time she was mentally conscious, trapped inside a body that refused to move. She said: “Doctors would ...

AT JUST 14 years old, Trinity Shores thought she was coming down with a bad case of the flu. But the common virus left her in ...

Warning has been raised after a lack of round-the-clock dietetic care contributed to a woman's death, a coronor's report has ...

Early launch numbers of Brinsupri are so strong that Insmed couldn’t wait for the J.P. Morgan Healthcare Conference to share ...